Global Opioid Induced Constipation (OIC) Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Opioid Induced Constipation (OIC) Drug market size was valued at US$ 2476 million in 2023. With growing demand in downstream market, the Opioid Induced Constipation (OIC) Drug is forecast to a readjusted size of US$ 3431.3 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Opioid Induced Constipation (OIC) Drug market. Opioid Induced Constipation (OIC) Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioid Induced Constipation (OIC) Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioid Induced Constipation (OIC) Drug market.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Opioid Induced Constipation (OIC) Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Opioid Induced Constipation (OIC) Drug market. It may include historical data, market segmentation by Type (e.g., Lubiprostone, Methyl Naltrexone Bromide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioid Induced Constipation (OIC) Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioid Induced Constipation (OIC) Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Opioid Induced Constipation (OIC) Drug industry. This include advancements in Opioid Induced Constipation (OIC) Drug technology, Opioid Induced Constipation (OIC) Drug new entrants, Opioid Induced Constipation (OIC) Drug new investment, and other innovations that are shaping the future of Opioid Induced Constipation (OIC) Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioid Induced Constipation (OIC) Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Opioid Induced Constipation (OIC) Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioid Induced Constipation (OIC) Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioid Induced Constipation (OIC) Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioid Induced Constipation (OIC) Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioid Induced Constipation (OIC) Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioid Induced Constipation (OIC) Drug market.
Market Segmentation:
Opioid Induced Constipation (OIC) Drug market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Opioid Induced Constipation (OIC) Drug market?
What factors are driving Opioid Induced Constipation (OIC) Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Induced Constipation (OIC) Drug market opportunities vary by end market size?
How does Opioid Induced Constipation (OIC) Drug break out type, distribution channel?
According to our LPI (LP Information) latest study, the global Opioid Induced Constipation (OIC) Drug market size was valued at US$ 2476 million in 2023. With growing demand in downstream market, the Opioid Induced Constipation (OIC) Drug is forecast to a readjusted size of US$ 3431.3 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Opioid Induced Constipation (OIC) Drug market. Opioid Induced Constipation (OIC) Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioid Induced Constipation (OIC) Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioid Induced Constipation (OIC) Drug market.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Opioid Induced Constipation (OIC) Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Opioid Induced Constipation (OIC) Drug market. It may include historical data, market segmentation by Type (e.g., Lubiprostone, Methyl Naltrexone Bromide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioid Induced Constipation (OIC) Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioid Induced Constipation (OIC) Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Opioid Induced Constipation (OIC) Drug industry. This include advancements in Opioid Induced Constipation (OIC) Drug technology, Opioid Induced Constipation (OIC) Drug new entrants, Opioid Induced Constipation (OIC) Drug new investment, and other innovations that are shaping the future of Opioid Induced Constipation (OIC) Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioid Induced Constipation (OIC) Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Opioid Induced Constipation (OIC) Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioid Induced Constipation (OIC) Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioid Induced Constipation (OIC) Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioid Induced Constipation (OIC) Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioid Induced Constipation (OIC) Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioid Induced Constipation (OIC) Drug market.
Market Segmentation:
Opioid Induced Constipation (OIC) Drug market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value.
Segmentation by type
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ironwood Pharmaceuticals
- Daiichi Sankyo Co
- Pfizer
- Progenics Pharmaceuticals
- Shionogi &
- Allergan
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma
- Mundipharma International Limited
- Ono Pharmaceutical
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
What is the 10-year outlook for the global Opioid Induced Constipation (OIC) Drug market?
What factors are driving Opioid Induced Constipation (OIC) Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Induced Constipation (OIC) Drug market opportunities vary by end market size?
How does Opioid Induced Constipation (OIC) Drug break out type, distribution channel?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Country/Region, 2019, 2023 & 2030
2.2 Opioid Induced Constipation (OIC) Drug Segment by Type
2.2.1 Lubiprostone
2.2.2 Methyl Naltrexone Bromide
2.2.3 Naldemedine
2.2.4 Alvimopan
2.2.5 Other
2.3 Opioid Induced Constipation (OIC) Drug Sales by Type
2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2019-2024)
2.4 Opioid Induced Constipation (OIC) Drug Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
2.5.1 Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2019-2024)
2.5.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Distribution Channel (2019-2024)
2.5.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2019-2024)
3 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG BY COMPANY
3.1 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
3.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Company (2019-2024)
3.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2019-2024)
3.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2019-2024)
3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2019-2024)
3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Company
3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Location Distribution
3.4.2 Players Opioid Induced Constipation (OIC) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioid Induced Constipation (OIC) Drug Sales Growth
4.4 APAC Opioid Induced Constipation (OIC) Drug Sales Growth
4.5 Europe Opioid Induced Constipation (OIC) Drug Sales Growth
4.6 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Growth
5 AMERICAS
5.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country
5.1.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024)
5.1.2 Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024)
5.2 Americas Opioid Induced Constipation (OIC) Drug Sales by Type
5.3 Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region
6.1.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2019-2024)
6.1.2 APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2019-2024)
6.2 APAC Opioid Induced Constipation (OIC) Drug Sales by Type
6.3 APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Induced Constipation (OIC) Drug by Country
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024)
7.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Type
7.3 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug by Country
8.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type
8.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug
10.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
10.4 Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Induced Constipation (OIC) Drug Distributors
11.3 Opioid Induced Constipation (OIC) Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
12.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region
12.1.1 Global Opioid Induced Constipation (OIC) Drug Forecast by Region (2025-2030)
12.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Induced Constipation (OIC) Drug Forecast by Type
12.7 Global Opioid Induced Constipation (OIC) Drug Forecast by Distribution Channel
13 KEY PLAYERS ANALYSIS
13.1 Ironwood Pharmaceuticals
13.1.1 Ironwood Pharmaceuticals Company Information
13.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Ironwood Pharmaceuticals Main Business Overview
13.1.5 Ironwood Pharmaceuticals Latest Developments
13.2 Daiichi Sankyo Co
13.2.1 Daiichi Sankyo Co Company Information
13.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Daiichi Sankyo Co Main Business Overview
13.2.5 Daiichi Sankyo Co Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Progenics Pharmaceuticals
13.4.1 Progenics Pharmaceuticals Company Information
13.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Progenics Pharmaceuticals Main Business Overview
13.4.5 Progenics Pharmaceuticals Latest Developments
13.5 Shionogi &
13.5.1 Shionogi & Company Information
13.5.2 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shionogi & Main Business Overview
13.5.5 Shionogi & Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Information
13.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Nektar Therapeutics Main Business Overview
13.7.5 Nektar Therapeutics Latest Developments
13.8 Purdue Pharma
13.8.1 Purdue Pharma Company Information
13.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Purdue Pharma Main Business Overview
13.8.5 Purdue Pharma Latest Developments
13.9 S.L.A. Pharma
13.9.1 S.L.A. Pharma Company Information
13.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 S.L.A. Pharma Main Business Overview
13.9.5 S.L.A. Pharma Latest Developments
13.10 Mundipharma International Limited
13.10.1 Mundipharma International Limited Company Information
13.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mundipharma International Limited Main Business Overview
13.10.5 Mundipharma International Limited Latest Developments
13.11 Ono Pharmaceutical
13.11.1 Ono Pharmaceutical Company Information
13.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Ono Pharmaceutical Main Business Overview
13.11.5 Ono Pharmaceutical Latest Developments
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Takeda Pharmaceutical Company Limited Company Information
13.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.12.5 Takeda Pharmaceutical Company Limited Latest Developments
13.13 Theravance Biopharma
13.13.1 Theravance Biopharma Company Information
13.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Theravance Biopharma Main Business Overview
13.13.5 Theravance Biopharma Latest Developments
13.14 Bausch Health
13.14.1 Bausch Health Company Information
13.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bausch Health Main Business Overview
13.14.5 Bausch Health Latest Developments
13.15 Cosmo Pharmaceuticals SA
13.15.1 Cosmo Pharmaceuticals SA Company Information
13.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Cosmo Pharmaceuticals SA Main Business Overview
13.15.5 Cosmo Pharmaceuticals SA Latest Developments
13.16 Daewoong Pharmaceutical
13.16.1 Daewoong Pharmaceutical Company Information
13.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Daewoong Pharmaceutical Main Business Overview
13.16.5 Daewoong Pharmaceutical Latest Developments
13.17 C.B. Fleet Company
13.17.1 C.B. Fleet Company Company Information
13.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 C.B. Fleet Company Main Business Overview
13.17.5 C.B. Fleet Company Latest Developments
13.18 Sucampo Pharmaceuticals
13.18.1 Sucampo Pharmaceuticals Company Information
13.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Sucampo Pharmaceuticals Main Business Overview
13.18.5 Sucampo Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Country/Region, 2019, 2023 & 2030
2.2 Opioid Induced Constipation (OIC) Drug Segment by Type
2.2.1 Lubiprostone
2.2.2 Methyl Naltrexone Bromide
2.2.3 Naldemedine
2.2.4 Alvimopan
2.2.5 Other
2.3 Opioid Induced Constipation (OIC) Drug Sales by Type
2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2019-2024)
2.4 Opioid Induced Constipation (OIC) Drug Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
2.5.1 Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2019-2024)
2.5.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Distribution Channel (2019-2024)
2.5.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2019-2024)
3 GLOBAL OPIOID INDUCED CONSTIPATION (OIC) DRUG BY COMPANY
3.1 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
3.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Company (2019-2024)
3.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2019-2024)
3.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2019-2024)
3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2019-2024)
3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Company
3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Location Distribution
3.4.2 Players Opioid Induced Constipation (OIC) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioid Induced Constipation (OIC) Drug Sales Growth
4.4 APAC Opioid Induced Constipation (OIC) Drug Sales Growth
4.5 Europe Opioid Induced Constipation (OIC) Drug Sales Growth
4.6 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Growth
5 AMERICAS
5.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country
5.1.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024)
5.1.2 Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024)
5.2 Americas Opioid Induced Constipation (OIC) Drug Sales by Type
5.3 Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region
6.1.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2019-2024)
6.1.2 APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2019-2024)
6.2 APAC Opioid Induced Constipation (OIC) Drug Sales by Type
6.3 APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Induced Constipation (OIC) Drug by Country
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024)
7.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Type
7.3 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug by Country
8.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type
8.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug
10.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
10.4 Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Induced Constipation (OIC) Drug Distributors
11.3 Opioid Induced Constipation (OIC) Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
12.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region
12.1.1 Global Opioid Induced Constipation (OIC) Drug Forecast by Region (2025-2030)
12.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Induced Constipation (OIC) Drug Forecast by Type
12.7 Global Opioid Induced Constipation (OIC) Drug Forecast by Distribution Channel
13 KEY PLAYERS ANALYSIS
13.1 Ironwood Pharmaceuticals
13.1.1 Ironwood Pharmaceuticals Company Information
13.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Ironwood Pharmaceuticals Main Business Overview
13.1.5 Ironwood Pharmaceuticals Latest Developments
13.2 Daiichi Sankyo Co
13.2.1 Daiichi Sankyo Co Company Information
13.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Daiichi Sankyo Co Main Business Overview
13.2.5 Daiichi Sankyo Co Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Progenics Pharmaceuticals
13.4.1 Progenics Pharmaceuticals Company Information
13.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Progenics Pharmaceuticals Main Business Overview
13.4.5 Progenics Pharmaceuticals Latest Developments
13.5 Shionogi &
13.5.1 Shionogi & Company Information
13.5.2 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shionogi & Main Business Overview
13.5.5 Shionogi & Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Information
13.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Nektar Therapeutics Main Business Overview
13.7.5 Nektar Therapeutics Latest Developments
13.8 Purdue Pharma
13.8.1 Purdue Pharma Company Information
13.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Purdue Pharma Main Business Overview
13.8.5 Purdue Pharma Latest Developments
13.9 S.L.A. Pharma
13.9.1 S.L.A. Pharma Company Information
13.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 S.L.A. Pharma Main Business Overview
13.9.5 S.L.A. Pharma Latest Developments
13.10 Mundipharma International Limited
13.10.1 Mundipharma International Limited Company Information
13.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mundipharma International Limited Main Business Overview
13.10.5 Mundipharma International Limited Latest Developments
13.11 Ono Pharmaceutical
13.11.1 Ono Pharmaceutical Company Information
13.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Ono Pharmaceutical Main Business Overview
13.11.5 Ono Pharmaceutical Latest Developments
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Takeda Pharmaceutical Company Limited Company Information
13.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.12.5 Takeda Pharmaceutical Company Limited Latest Developments
13.13 Theravance Biopharma
13.13.1 Theravance Biopharma Company Information
13.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Theravance Biopharma Main Business Overview
13.13.5 Theravance Biopharma Latest Developments
13.14 Bausch Health
13.14.1 Bausch Health Company Information
13.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bausch Health Main Business Overview
13.14.5 Bausch Health Latest Developments
13.15 Cosmo Pharmaceuticals SA
13.15.1 Cosmo Pharmaceuticals SA Company Information
13.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Cosmo Pharmaceuticals SA Main Business Overview
13.15.5 Cosmo Pharmaceuticals SA Latest Developments
13.16 Daewoong Pharmaceutical
13.16.1 Daewoong Pharmaceutical Company Information
13.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Daewoong Pharmaceutical Main Business Overview
13.16.5 Daewoong Pharmaceutical Latest Developments
13.17 C.B. Fleet Company
13.17.1 C.B. Fleet Company Company Information
13.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 C.B. Fleet Company Main Business Overview
13.17.5 C.B. Fleet Company Latest Developments
13.18 Sucampo Pharmaceuticals
13.18.1 Sucampo Pharmaceuticals Company Information
13.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Sucampo Pharmaceuticals Main Business Overview
13.18.5 Sucampo Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Methyl Naltrexone Bromide
Table 5. Major Players of Naldemedine
Table 6. Major Players of Alvimopan
Table 7. Major Players of Other
Table 8. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Table 10. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 14. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2019-2024)
Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2019-2024)
Table 17. Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2019-2024) & (USD/Unit)
Table 18. Global Opioid Induced Constipation (OIC) Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2019-2024)
Table 20. Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Opioid Induced Constipation (OIC) Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution and Sales Area
Table 24. Players Opioid Induced Constipation (OIC) Drug Products Offered
Table 25. Opioid Induced Constipation (OIC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Opioid Induced Constipation (OIC) Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Opioid Induced Constipation (OIC) Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Opioid Induced Constipation (OIC) Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 42. APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 48. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2019-2024)
Table 50. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 54. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation (OIC) Drug
Table 61. Key Market Challenges & Risks of Opioid Induced Constipation (OIC) Drug
Table 62. Key Industry Trends of Opioid Induced Constipation (OIC) Drug
Table 63. Opioid Induced Constipation (OIC) Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Opioid Induced Constipation (OIC) Drug Distributors List
Table 66. Opioid Induced Constipation (OIC) Drug Customer List
Table 67. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Distribution Channel (2025-2030) & (K Units)
Table 80. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Distribution Channel (2025-2030) & ($ Millions)
Table 81. Ironwood Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 83. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Ironwood Pharmaceuticals Main Business
Table 85. Ironwood Pharmaceuticals Latest Developments
Table 86. Daiichi Sankyo Co Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 88. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Daiichi Sankyo Co Main Business
Table 90. Daiichi Sankyo Co Latest Developments
Table 91. Pfizer Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 93. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. Progenics Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 98. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Progenics Pharmaceuticals Main Business
Table 100. Progenics Pharmaceuticals Latest Developments
Table 101. Shionogi & Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 103. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Shionogi & Main Business
Table 105. Shionogi & Latest Developments
Table 106. Allergan Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 108. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Allergan Main Business
Table 110. Allergan Latest Developments
Table 111. Nektar Therapeutics Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 113. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Nektar Therapeutics Main Business
Table 115. Nektar Therapeutics Latest Developments
Table 116. Purdue Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 118. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Purdue Pharma Main Business
Table 120. Purdue Pharma Latest Developments
Table 121. S.L.A. Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 123. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. S.L.A. Pharma Main Business
Table 125. S.L.A. Pharma Latest Developments
Table 126. Mundipharma International Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 128. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Mundipharma International Limited Main Business
Table 130. Mundipharma International Limited Latest Developments
Table 131. Ono Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 133. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Ono Pharmaceutical Main Business
Table 135. Ono Pharmaceutical Latest Developments
Table 136. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 138. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Takeda Pharmaceutical Company Limited Main Business
Table 140. Takeda Pharmaceutical Company Limited Latest Developments
Table 141. Theravance Biopharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 143. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Theravance Biopharma Main Business
Table 145. Theravance Biopharma Latest Developments
Table 146. Bausch Health Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 148. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Bausch Health Main Business
Table 150. Bausch Health Latest Developments
Table 151. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 153. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Cosmo Pharmaceuticals SA Main Business
Table 155. Cosmo Pharmaceuticals SA Latest Developments
Table 156. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 158. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Daewoong Pharmaceutical Main Business
Table 160. Daewoong Pharmaceutical Latest Developments
Table 161. C.B. Fleet Company Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 163. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. C.B. Fleet Company Main Business
Table 165. C.B. Fleet Company Latest Developments
Table 166. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 168. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Sucampo Pharmaceuticals Main Business
Table 170. Sucampo Pharmaceuticals Latest Developments
Table 1. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Methyl Naltrexone Bromide
Table 5. Major Players of Naldemedine
Table 6. Major Players of Alvimopan
Table 7. Major Players of Other
Table 8. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Table 10. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 14. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2019-2024)
Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2019-2024)
Table 17. Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2019-2024) & (USD/Unit)
Table 18. Global Opioid Induced Constipation (OIC) Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2019-2024)
Table 20. Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Opioid Induced Constipation (OIC) Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution and Sales Area
Table 24. Players Opioid Induced Constipation (OIC) Drug Products Offered
Table 25. Opioid Induced Constipation (OIC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Opioid Induced Constipation (OIC) Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Opioid Induced Constipation (OIC) Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Opioid Induced Constipation (OIC) Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 42. APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 48. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2019-2024)
Table 50. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 54. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation (OIC) Drug
Table 61. Key Market Challenges & Risks of Opioid Induced Constipation (OIC) Drug
Table 62. Key Industry Trends of Opioid Induced Constipation (OIC) Drug
Table 63. Opioid Induced Constipation (OIC) Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Opioid Induced Constipation (OIC) Drug Distributors List
Table 66. Opioid Induced Constipation (OIC) Drug Customer List
Table 67. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Distribution Channel (2025-2030) & (K Units)
Table 80. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Distribution Channel (2025-2030) & ($ Millions)
Table 81. Ironwood Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 83. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Ironwood Pharmaceuticals Main Business
Table 85. Ironwood Pharmaceuticals Latest Developments
Table 86. Daiichi Sankyo Co Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 88. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Daiichi Sankyo Co Main Business
Table 90. Daiichi Sankyo Co Latest Developments
Table 91. Pfizer Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 93. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. Progenics Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 98. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Progenics Pharmaceuticals Main Business
Table 100. Progenics Pharmaceuticals Latest Developments
Table 101. Shionogi & Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 103. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Shionogi & Main Business
Table 105. Shionogi & Latest Developments
Table 106. Allergan Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 108. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Allergan Main Business
Table 110. Allergan Latest Developments
Table 111. Nektar Therapeutics Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 113. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Nektar Therapeutics Main Business
Table 115. Nektar Therapeutics Latest Developments
Table 116. Purdue Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 118. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Purdue Pharma Main Business
Table 120. Purdue Pharma Latest Developments
Table 121. S.L.A. Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 123. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. S.L.A. Pharma Main Business
Table 125. S.L.A. Pharma Latest Developments
Table 126. Mundipharma International Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 128. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Mundipharma International Limited Main Business
Table 130. Mundipharma International Limited Latest Developments
Table 131. Ono Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 133. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Ono Pharmaceutical Main Business
Table 135. Ono Pharmaceutical Latest Developments
Table 136. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 138. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Takeda Pharmaceutical Company Limited Main Business
Table 140. Takeda Pharmaceutical Company Limited Latest Developments
Table 141. Theravance Biopharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 143. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Theravance Biopharma Main Business
Table 145. Theravance Biopharma Latest Developments
Table 146. Bausch Health Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 148. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Bausch Health Main Business
Table 150. Bausch Health Latest Developments
Table 151. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 153. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Cosmo Pharmaceuticals SA Main Business
Table 155. Cosmo Pharmaceuticals SA Latest Developments
Table 156. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 158. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Daewoong Pharmaceutical Main Business
Table 160. Daewoong Pharmaceutical Latest Developments
Table 161. C.B. Fleet Company Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 163. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. C.B. Fleet Company Main Business
Table 165. C.B. Fleet Company Latest Developments
Table 166. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 168. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Sucampo Pharmaceuticals Main Business
Table 170. Sucampo Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Induced Constipation (OIC) Drug
Figure 2. Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Opioid Induced Constipation (OIC) Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Lubiprostone
Figure 10. Product Picture of Methyl Naltrexone Bromide
Figure 11. Product Picture of Naldemedine
Figure 12. Product Picture of Alvimopan
Figure 13. Product Picture of Other
Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2023
Figure 15. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2019-2024)
Figure 16. Opioid Induced Constipation (OIC) Drug Consumed in Hospital Pharmacies
Figure 17. Global Opioid Induced Constipation (OIC) Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. Opioid Induced Constipation (OIC) Drug Consumed in Retail Pharmacies
Figure 19. Global Opioid Induced Constipation (OIC) Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 20. Opioid Induced Constipation (OIC) Drug Consumed in Online Pharmacies
Figure 21. Global Opioid Induced Constipation (OIC) Drug Market: Online Pharmacies (2019-2024) & (K Units)
Figure 22. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2023)
Figure 23. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2023
Figure 24. Opioid Induced Constipation (OIC) Drug Sales Market by Company in 2023 (K Units)
Figure 25. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2023
Figure 26. Opioid Induced Constipation (OIC) Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company in 2023
Figure 28. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 31. Americas Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 33. APAC Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 35. Europe Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2023
Figure 39. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2023
Figure 40. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 42. United States Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2023
Figure 47. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions in 2023
Figure 48. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 50. China Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2023
Figure 58. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2023
Figure 59. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 61. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 70. Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2023
Figure 76. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
Figure 77. Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
Figure 78. Channels of Distribution
Figure 79. Global Opioid Induced Constipation (OIC) Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Distribution Channel (2025-2030)
Figure 84. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Distribution Channel (2025-2030)
Figure 1. Picture of Opioid Induced Constipation (OIC) Drug
Figure 2. Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Opioid Induced Constipation (OIC) Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Lubiprostone
Figure 10. Product Picture of Methyl Naltrexone Bromide
Figure 11. Product Picture of Naldemedine
Figure 12. Product Picture of Alvimopan
Figure 13. Product Picture of Other
Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2023
Figure 15. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2019-2024)
Figure 16. Opioid Induced Constipation (OIC) Drug Consumed in Hospital Pharmacies
Figure 17. Global Opioid Induced Constipation (OIC) Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. Opioid Induced Constipation (OIC) Drug Consumed in Retail Pharmacies
Figure 19. Global Opioid Induced Constipation (OIC) Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 20. Opioid Induced Constipation (OIC) Drug Consumed in Online Pharmacies
Figure 21. Global Opioid Induced Constipation (OIC) Drug Market: Online Pharmacies (2019-2024) & (K Units)
Figure 22. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2023)
Figure 23. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2023
Figure 24. Opioid Induced Constipation (OIC) Drug Sales Market by Company in 2023 (K Units)
Figure 25. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2023
Figure 26. Opioid Induced Constipation (OIC) Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company in 2023
Figure 28. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 31. Americas Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 33. APAC Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 35. Europe Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2023
Figure 39. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2023
Figure 40. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 42. United States Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2023
Figure 47. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions in 2023
Figure 48. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 50. China Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2023
Figure 58. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2023
Figure 59. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 61. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 70. Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Opioid Induced Constipation (OIC) Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2023
Figure 76. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
Figure 77. Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
Figure 78. Channels of Distribution
Figure 79. Global Opioid Induced Constipation (OIC) Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Distribution Channel (2025-2030)
Figure 84. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Distribution Channel (2025-2030)
